ERBB2 and gastric cancer: [90] performed metabolomic profiling on 112 gastric cancer patients and 112 healthy controls, reporting relationships between alanine, aspartate, and glutamate metabolism, glycolysis/gluconeogenesis, and HER2 levels in gastric cancer.